Satsuma Pharmaceuticals Inc (STSA) stock has fallen -76.58% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives STSA stock a score of 11 out of a possible 100.
That rank is mainly influenced by a short-term technical score of 5. STSA's rank also includes a fundamental score of 10. In addition to the average rating from Wall Street analysts, STSA stock has a mean target price of 5. This means analysts expect the stock to decrease 26.69% over the next 12 months. The long-term technical score for STSA is 17.
What's Happening with STSA Stock Today
Satsuma Pharmaceuticals Inc (STSA) stock is up 20.07% while the S&P 500 is up 1.51% as of 9:41 AM on Monday, Mar 1. STSA is up $1.14 from the previous closing price of $5.68 on volume of 458,677 shares. Over the past year the S&P 500 has gained 25.19% while STSA has fallen -76.58%. STSA lost -$2.64 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Satsuma Pharmaceuticals Inc (STSA) Stock.
